Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

急性 COVID-19 患者体内针对 SARS-CoV-2 的抗原特异性适应性免疫及其与年龄和疾病严重程度的关系

阅读:11
作者:Carolyn Rydyznski Moderbacher ,Sydney I Ramirez ,Jennifer M Dan ,Alba Grifoni ,Kathryn M Hastie ,Daniela Weiskopf ,Simon Belanger ,Robert K Abbott ,Christina Kim ,Jinyong Choi ,Yu Kato ,Eleanor G Crotty ,Cheryl Kim ,Stephen A Rawlings ,Jose Mateus ,Long Ping Victor Tse ,April Frazier ,Ralph Baric ,Bjoern Peters ,Jason Greenbaum ,Erica Ollmann Saphire ,Davey M Smith ,Alessandro Sette ,Shane Crotty

Abstract

Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4+ and CD8+ T cell and neutralizing antibody responses in acute and convalescent subjects. SARS-CoV-2-specific CD4+ and CD8+ T cells were each associated with milder disease. Coordinated SARS-CoV-2-specific adaptive immune responses were associated with milder disease, suggesting roles for both CD4+ and CD8+ T cells in protective immunity in COVID-19. Notably, coordination of SARS-CoV-2 antigen-specific responses was disrupted in individuals ≥ 65 years old. Scarcity of naive T cells was also associated with aging and poor disease outcomes. A parsimonious explanation is that coordinated CD4+ T cell, CD8+ T cell, and antibody responses are protective, but uncoordinated responses frequently fail to control disease, with a connection between aging and impaired adaptive immune responses to SARS-CoV-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。